- Home
- CRVS vs VOXR Comparison
CRVS vs VOXR Comparison
Compare CRVS & VOXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRVS
- VOXR
- Stock Information
- Founded
- CRVS 2014
- VOXR 2014
- Country
- CRVS United States
- VOXR United States
- Employees
- CRVS N/A
- VOXR N/A
- Industry
- CRVS Biotechnology: Pharmaceutical Preparations
- VOXR Precious Metals
- Sector
- CRVS Health Care
- VOXR Basic Materials
- Exchange
- CRVS Nasdaq
- VOXR Nasdaq
- Market Cap
- CRVS 206.5M
- VOXR 168.0M
- IPO Year
- CRVS 2016
- VOXR N/A
- Fundamental
- Price
- CRVS $3.61
- VOXR $3.33
- Analyst Decision
- CRVS Strong Buy
- VOXR
- Analyst Count
- CRVS 3
- VOXR 0
- Target Price
- CRVS $16.33
- VOXR N/A
- AVG Volume (30 Days)
- CRVS 1.6M
- VOXR 191.1K
- Earning Date
- CRVS 05-08-2025
- VOXR 05-15-2025
- Dividend Yield
- CRVS N/A
- VOXR 1.50%
- EPS Growth
- CRVS N/A
- VOXR N/A
- EPS
- CRVS N/A
- VOXR N/A
- Revenue
- CRVS N/A
- VOXR $10,845,445.00
- Revenue This Year
- CRVS N/A
- VOXR $16.51
- Revenue Next Year
- CRVS N/A
- VOXR $4.60
- P/E Ratio
- CRVS N/A
- VOXR N/A
- Revenue Growth
- CRVS N/A
- VOXR N/A
- 52 Week Low
- CRVS $1.75
- VOXR $1.93
- 52 Week High
- CRVS $10.00
- VOXR $3.57
- Technical
- Relative Strength Index (RSI)
- CRVS 50.22
- VOXR 56.97
- Support Level
- CRVS $3.46
- VOXR $2.97
- Resistance Level
- CRVS $4.53
- VOXR $3.35
- Average True Range (ATR)
- CRVS 0.28
- VOXR 0.16
- MACD
- CRVS 0.02
- VOXR -0.01
- Stochastic Oscillator
- CRVS 32.60
- VOXR 69.35
About CRVS Corvus Pharmaceuticals Inc.
Corvus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The other products include Ciforadenant (CPI-444) and Mupadolimab (CPI-006).
About VOXR Vox Royalty Corp.
Vox Royalty Corp is a returns-focused mining royalty company with a portfolio of royalties and streams spanning eight jurisdictions. It has built intellectual property, a technically focused transactional team, and a sourcing network which has allowed Vox to target the highest returns on royalty acquisitions in the mining royalty sector. The company geographically operates Australia, Nigeria, USA, and Brazil.